Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Janssen highlights continued commitment to #cardiovascular and metabolic healthcare solutions with late-breaking research at the first fully virtual #ACC20/#WCCardio http://bit.ly/3ddwFNr “The depth of our research at ACC this year is a testament to how our medicines help improve care for people living with cardiovascular diseases, type 2 diabetes and diabetic kidney disease,” said James List, M.D., Ph.D., Global Therapeutic Area Head, Cardiovascular &Metabolism, Janssen Research &Development, LLC. “We look forward to sharing the latest evidence from our portfolio that we believe will continue to help shape clinical practice.” Janssen’s cardiovascular and metabolism franchise includes XARELTO®, a direct oral anticoagulant (DOAC) with eight indications – the most of any DOAC in the class – and INVOK...
Publication date: Available online 30 May 2020Source: Journal of American Association for Pediatric Ophthalmology and StrabismusAuthor(s): Gamze Dereli Can, Muhammet Furkan Korkmaz, Mehmet Erol Can
Publication date: Available online 30 May 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Alessandra Graziottin, Filippo Murina, Dania Gambini, Stefania Taraborrelli, Barbara Gardella, Maria Campo, the VuNet Study Group
Publication date: Available online 30 May 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Anna Vittoria Mattioli, Susanna Sciomer, Camilla Cocchi, Silvia Maffei, Sabina Gallina
Publication date: Available online 30 May 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang
Publication date: Available online 30 May 2020Source: Annals of Medicine and SurgeryAuthor(s): Abu Bakar H. Bhatti, Roshni Z. Jafri, Nasir A. Khan
Publication date: Available online 30 May 2020Source: Comparative Immunology, Microbiology and Infectious DiseasesAuthor(s): Hai Xu, Yale Niu, Weiming Hong, Weixin Liu, Xiaoxin Zuo, Xi Bao, Changming Guo, Yu Lu, Bihua Deng
Publication date: Available online 30 May 2020Source: Comparative Immunology, Microbiology and Infectious DiseasesAuthor(s): Ahmad Erfanmanesh, Arash Ghalyanchilangeroudi, Donya Nikaein, Hossein Hosseini, Tahereh Mohajerfar
[Frequency and predictive factors of venous thrombosis in Behçet's disease]. Rev Med Interne. 2020 May 26;: Authors: Ha-Ou-Nou FZ, Essaadouni L Abstract OBJECTIVE: To investigate the clinical features of venous thrombosis in patients with Behçet's disease and to determine the patients at high risk for this complication. METHODS: We retrospectively studied patients with venous thrombosis (n = 157) who were followed up in the Internal Medicine department. These patients were divided into two groups according to the existence (n = 60, 38.2%) or not (n = 97, 61.8%) of Beh&cced...
Publication date: Available online 30 May 2020Source: Mechanisms of Ageing and DevelopmentAuthor(s): A. Gedmantaite, C.A. Celis-Morales, Frederick Ho, JP Pell, A. Ratkevicius, S.R. Gray
Publication date: Available online 30 May 2020Source: Molecular MetabolismAuthor(s): Veronika Leiss, Annika Schönsiegel, Thorsten Gnad, Johannes Kerner, Jyotsna Kaur, Tina Sartorius, Jürgen Machann, Fritz Schick, Lutz Birnbaumer, Hans-Ulrich Häring, Alexander Pfeifer, Bernd Nürnberg
More News: Alcoholism | Allergy & Immunology | Anesthesia | Anesthesiology | Antiphospholipid Syndrome | Aspirin | Atrial Fibrillation | Babies | Babies Heart Conditions | Back Pain | Bleeding | Brain | Breastfed | Canagliflozin | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Child Development | Children | Chronic Pain | Clopidogrel | Complementary Medicine | Cough | Coumadin | Denmark Health | Dentistry | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Diabetic Ulcers | Diets | Emergency Medicine | Endocrinology | Epistaxis (Nosebleeds) | Headache | Health Management | Heart | Heart Attack | Heart Disease | Heart Failure | Heart Transplant | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Herbs | Hives | Hospitals | Hughes Syndrome | Hypertension | Incontinence | Infectious Diseases | Insulin | Invokana | Kidney Transplant | Learning | Legislation | Liver | Liver Transplant | Lovenox | Lung Transplant | Men | Migraine | Milk | Neurology | Neuroscience | Neurosurgery | Norvir | Nutrition | Orthopaedics | Pain | Pancreas | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Phenobarbital | Phenytoin | Plavix | Politics | Pregnancy | Profits and Losses | Pulmonary Hypertension | Pulmonary Thromboembolism | Science | SGLT2 Inhibitors | Skin | Sodium | Sodium Chloride | Sports Medicine | Stroke | Study | Sugar | Thrombosis | Tuberculosis | Universities & Medical Training | Urinary Tract Infections | Urology & Nephrology | Vaccines | Vitamins | Warfarin | Warnings | Women